Literature DB >> 29932968

Time trends in the prevalence of cancer and non-cancer diseases among older U.S. adults: Medicare-based analysis.

Igor Akushevich1, Julia Kravchenko2, Arseniy P Yashkin3, Anatoliy I Yashin3.   

Abstract

Longer lifespan is accompanied by a larger number of chronic diseases among older adults. Because of a growing proportion of older adults in the U.S., this brings the problem of age-related morbidity to the forefront as a major contributor to rising medical expenditures. We evaluated 15-year time trends (from 1998 to 2013) in the prevalence of 48 acute and chronic non-cancer diseases and cancers in older U.S. adults aged 65+ and estimated the annual percentage changes of these prevalence trends using SEER-Medicare and HRS-Medicare data. We found that age-adjusted prevalence of cancers of kidney, pancreas, and melanoma, as well as diabetes, renal disease, limb fracture, depression, anemia, weight deficiency, dementia/Alzheimer's disease, drug/medications abuse and several other diseases/conditions increased over time. Conversely, prevalence of myocardial infarction, heart failure, cardiomyopathy, pneumonia/influenza, peptic ulcer, and gastrointestinal bleeding, among others, decreased over time. There are also diseases whose prevalence did not change substantially over time, e.g., a group of fast progressing cancers and rheumatoid arthritis. Analysis of trends of multiple diseases performed simultaneously within one study design with focus on the same time interval and the same population for all diseases allowed us to provide insight into the epidemiology of these conditions and identify the most alarming and/or unexpected trends and trade-offs. The obtained results can be used for health expenditures planning for growing sector of older adults in the U.S.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age-adjusted rate; Annual percent change; Disease prevalence; Epidemiology; Medicare; Time trends

Mesh:

Year:  2018        PMID: 29932968      PMCID: PMC6876855          DOI: 10.1016/j.exger.2018.06.017

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  87 in total

1.  Long-term trends in the incidence of and survival with heart failure.

Authors:  Daniel Levy; Satish Kenchaiah; Martin G Larson; Emelia J Benjamin; Michelle J Kupka; Kalon K L Ho; Joanne M Murabito; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

2.  Cancer burden in the HIV-infected population in the United States.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Mitchell H Gail; H Irene Hall; Jianmin Li; Anil K Chaturvedi; Kishor Bhatia; Thomas S Uldrick; Robert Yarchoan; James J Goedert; Eric A Engels
Journal:  J Natl Cancer Inst       Date:  2011-04-11       Impact factor: 13.506

3.  Anemia increases risk for falls in hospitalized older adults: an evaluation of falls in 362 hospitalized, ambulatory, long-term care, and community patients.

Authors:  T S Dharmarajan; Sai Avula; Edward P Norkus
Journal:  J Am Med Dir Assoc       Date:  2007-03       Impact factor: 4.669

4.  Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

Authors:  Ian Janssen; Steven B Heymsfield; Robert Ross
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

Review 5.  Racial disparities in breast cancer outcome: insights into host-tumor interactions.

Authors:  Romano Demicheli; Michael W Retsky; William J M Hrushesky; Michael Baum; Isaac D Gukas; Ismail Jatoi
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

Review 6.  Long-term survival of cancer patients compared to heart failure and stroke: a systematic review.

Authors:  Vasileios Askoxylakis; Christian Thieke; Sven T Pleger; Patrick Most; Judith Tanner; Katja Lindel; Hugo A Katus; Jürgen Debus; Marc Bischof
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

7.  Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association.

Authors:  Bruce Ovbiagele; Larry B Goldstein; Randall T Higashida; Virginia J Howard; S Claiborne Johnston; Olga A Khavjou; Daniel T Lackland; Judith H Lichtman; Stephanie Mohl; Ralph L Sacco; Jeffrey L Saver; Justin G Trogdon
Journal:  Stroke       Date:  2013-05-22       Impact factor: 7.914

8.  Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996-2011.

Authors:  D H Chang; Robert A Bednarczyk; Edmund R Becker; Jason M Hockenberry; Paul S Weiss; Walter A Orenstein; Saad B Omer
Journal:  Vaccine       Date:  2015-12-17       Impact factor: 3.641

9.  Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns.

Authors:  Linda Morris Brown; David P Check; Susan S Devesa
Journal:  J Oncol       Date:  2012-04-17       Impact factor: 4.375

Review 10.  Depression as a major component of public health for older adults.

Authors:  Daniel P Chapman; Geraldine S Perry
Journal:  Prev Chronic Dis       Date:  2007-12-15       Impact factor: 2.830

View more
  3 in total

1.  Elevated Amygdala Activity in Young Adults With Familial Risk for Depression: A Potential Marker of Low Resilience.

Authors:  Tracy Barbour; Avram J Holmes; Amy H Farabaugh; Stephanie N DeCross; Garth Coombs; Emily A Boeke; Rick P F Wolthusen; Maren Nyer; Paola Pedrelli; Maurizio Fava; Daphne J Holt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-11-06

2.  Outcomes and Costs for Women After Breast Cancer: Preparing for Improved Survivorship of Medicare Beneficiaries.

Authors:  Arseniy P Yashkin; Rachel A Greenup; Galina Gorbunova; Igor Akushevich; Kevin C Oeffinger; E Shelley Hwang
Journal:  JCO Oncol Pract       Date:  2020-07-21

3.  Analysis of Time Trends in Alzheimer's Disease and Related Dementias Using Partitioning Approach.

Authors:  Igor Akushevich; Arseniy P Yashkin; Julia Kravchenko; Anatoliy I Yashin
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.